Market revenue in 2023 | USD 0.8 million |
Market revenue in 2030 | USD 1.1 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 25% in 2023. Horizon Databook has segmented the Denmark dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
In Denmark, the use of DBS collection cards has been on the rise in recent years, driven by their convenience and cost-effectiveness. DBS technology has been used in newborn screening programs, viral hepatitis screening, HIV diagnosis, and for monitoring patients on antiretroviral therapy.
The ability to collect blood samples at home or in remote areas has also increased the popularity of DBS collection cards. For instance, in 1975, screening for phenylketonuria was added to the Danish Neonatal Screening Program. Since then, the screening panel has grown significantly, and it currently includes cystic fibrosis, several fatty acid oxidation diseases, and congenital hypothyroidism.
Severe Combined Immunodeficiency (SCID) screening was added to the screening panel as the 18th condition in February 2020. The purpose of the screening was to find neonates with complete T-cell depletion and classical SCID.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark dried blood spot collection cards market , including forecasts for subscribers. This country databook contains high-level insights into Denmark dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account